Primary |
Acne |
81.9% |
Product Used For Unknown Indication |
7.6% |
Drug Use For Unknown Indication |
2.8% |
Local Swelling |
1.4% |
Rash |
1.4% |
Rash Pustular |
1.4% |
Scar |
1.4% |
Colitis Ulcerative |
0.7% |
Dry Skin |
0.7% |
Prophylaxis |
0.7% |
|
Drug Ineffective |
11.5% |
Erythema |
11.5% |
Product Quality Issue |
8.3% |
Swelling Face |
7.3% |
Urticaria |
7.3% |
Rash |
6.3% |
Dry Skin |
5.2% |
Pruritus |
5.2% |
Ill-defined Disorder |
4.2% |
Skin Irritation |
4.2% |
Acne |
3.1% |
Dermatitis Contact |
3.1% |
Drug Administration Error |
3.1% |
Sensory Disturbance |
3.1% |
Skin Discolouration |
3.1% |
Skin Exfoliation |
3.1% |
Sunburn |
3.1% |
Swelling |
3.1% |
Aspartate Aminotransferase Increased |
2.1% |
Expired Drug Administered |
2.1% |
|
Secondary |
Acne |
50.0% |
Dermatitis Atopic |
37.5% |
Dry Skin Prophylaxis |
12.5% |
|
Lymphadenopathy |
50.0% |
Sunburn |
50.0% |
|
Concomitant |
Acne |
40.1% |
Abdominal Pain |
10.1% |
Product Used For Unknown Indication |
6.0% |
Contraception |
4.8% |
Premenstrual Syndrome |
4.0% |
Anxiety |
3.8% |
Diarrhoea |
3.3% |
Breast Cancer |
3.0% |
Colitis Ulcerative |
3.0% |
Pulmonary Tuberculosis |
3.0% |
Depression |
2.8% |
Insomnia |
2.8% |
Headache |
2.3% |
Aspartate Aminotransferase Increased |
2.0% |
Dermatitis Acneiform |
2.0% |
Hepatic Neoplasm Malignant |
2.0% |
Asthma |
1.5% |
Oral Contraception |
1.3% |
Pain |
1.3% |
Abdominal Distension |
1.0% |
|
Pulmonary Embolism |
14.5% |
Pain |
10.9% |
Wheezing |
7.3% |
Colitis Ulcerative |
5.5% |
Deep Vein Thrombosis |
5.5% |
Liver Function Test Abnormal |
5.5% |
Tuberculosis |
5.5% |
Abdominal Distension |
3.6% |
Biliary Dyskinesia |
3.6% |
Cholecystitis |
3.6% |
Dermatitis |
3.6% |
Melanocytic Naevus |
3.6% |
Pneumatosis Intestinalis |
3.6% |
Pneumoperitoneum |
3.6% |
Proteinuria |
3.6% |
Suicidal Ideation |
3.6% |
Syncope |
3.6% |
Vascular Compression |
3.6% |
Vomiting |
3.6% |
Acne |
1.8% |
|